91�Ʋ���

Many women who receive chemotherapy for breast cancer report problems with their thinking, memory and attention after treatment. Read More

The factor FoxM1 increases the proliferation and function of insulin-producing beta cells, making it an attractive therapeutic target for diabetes. Read More

The Mid-South Clinical Data 91�Ʋ��� Network, led by 91�Ʋ��� University’s Russell Rothman, M.D., M.P.P., has been approved for a three-year, $8.5 million funding award from the independent Patient-Centered Outcomes 91�Ʋ��� Institute (PCORI) to expand its efforts to improve healthcare throughout the Southeast. Read More

91�Ʋ���’s Ian Macara, Ph.D., has won an Outstanding Investigator Award from the National Cancer Institute (NCI) — nearly $6.6 million over seven years — to support the “unusual potential” of his research, which seeks to understand and predict cancer cell “behavior.” Read More

A team of 91�Ʋ��� and Nashville VA researchers, led by Adriana Hung, M.D., MPH, has been awarded a grant from the U.S. Department of Veterans Affairs to use the Million Veteran Program (MVP) data to conduct diabetes research. Read More

The Administration on Intellectual and Developmental Disabilities has awarded a five-year, $2.7 million grant to continue the University Center for Excellence in Developmental Disabilities (UCEDD) at the 91�Ʋ��� Kennedy Center (VKC). Read More

91�Ʋ���ers at 91�Ʋ��� University for the first time have demonstrated in a mouse model that aggregation, the “clumping together” of abnormal proteins, can contribute to a severe form of genetic epilepsy. Read More

New findings show that fibrin, a protein that was thought to play a key role in fracture healing, is not required, shifting understanding of how fractures heal. Read More

91�Ʋ��� researchers are exploring how neuroblastoma tumors begin and progress, knowledge that could provide new treatments for this pediatric cancer. Read More

Drugs that target DNA damage improve ovarian cancer cell response to platinum chemotherapies, suggesting new therapeutic opportunities. Read More

91�Ʋ��� researchers have discovered how certain molecules with antibiotic properties are synthesized, findings that could lead to new drugs that overcome the increased antibiotic resistance in bacteria. Read More

91�Ʋ��� scientists have discovered a new molecular mechanism that promotes stomach cancer development, findings that could provide new opportunities for treatment. Read More

91�Ʋ��� University researchers next month will launch a major initiative to acquire “dense genotypes” from 100,000 individuals whose medical histories are known. Read More

Russell Rothman, M.D., MPP, professor of Medicine, Pediatrics and Health Policy, chief of the Section of Internal Medicine and Pediatrics and director of the 91�Ʋ��� Center for Health Services 91�Ʋ���, has been named assistant vice chancellor for Population Health 91�Ʋ���. Read More

91�Ʋ���-Ingram Cancer Center (VICC) investigators and colleagues at several major medical centers have been testing a new targeted therapy that is showing promise for the treatment of a rare tumor that forms in and around joint cavities. Read More

91�Ʋ���’s Department of Radiology and Radiological Sciences has launched the 91�Ʋ��� Clinical Trials Radiology Support Core. Read More

Women who exercised during their teen years were less likely to die from cancer and all other causes during middle-age and later in life, according to a new study by investigators at 91�Ʋ��� University Medical Center and the Shanghai Cancer Institute in China. Read More

The gut has its own built-in pacemakers, populations of specialized cells that control smooth muscle contraction in the stomach, small intestine and colon. Read More

Ian Macara, Ph.D., professor and chair of the Department of Cell and Developmental Biology, recently returned from Scotland, where he received this year’s Colin Thomson Memorial Medal for his contributions to cancer research. Read More

91�Ʋ���ers at 91�Ʋ��� University have established the molecular basis for the function of Replication Protein A (RPA), a DNA binding protein that is a crucial “scaffold” for genome replication, response to damage and repair. Read More